A decision system for the gross bench.
PathLogix is a dynamic checklist management and decision-making system. It combines a decision-tree model with voice recognition to generate the right checklist for the right specimen - in real time, in the lab.
Dynamic checklist generation
Real-time, context-aware checklists for Gross Description, Critical Measurements and Tumor Macroscopic Evaluation - driven by specimen type and pre-op ICD-10.
Decision-tree engine
A decision-tree model maps checklist criteria and contextual factors (task importance, prior decisions, environment) to the right next action at the bench.
Voice recognition pipeline
Voice input feeds directly into the decision tree, fine-tuned to handle natural variations of grossing commands and map them to the correct features.
Gross dictation templates
Standardized templates aligned to CAP Cancer Protocols and AJCC staging - no more free-text drift between PAs, labs or sites.
No-PHI by design
We integrate empty CAP checklists and public staging criteria. No patient identifiers, no HIPAA labeling bottleneck during model build-out.
Public-data trained
CAP Cancer Staging Checklists, AJCC criteria, WHO Classification of Tumours and NCCN guidelines form the foundation - auditable and updatable.
Three phases to lab deployment.
Define use cases and grossing scenarios with PA leadership. Select decision-tree architecture aligned to CAP protocols and target specimen types.
Train on CAP checklists, AJCC staging, NCCN guidelines and ICD-10 pre-op codes. No PHI, no label collection - protocols are public and general.
Integrate decision tree with voice recognition into one bench-facing application. Validate dynamic checklist generation against real-time PA input.

The standard, encoded.
PathLogix is developed by industry-leading Pathologists' Assistants - the people on the bench taking the critical measurements that determine cancer stage. Our model encodes the same standard we teach, so what a trainee learns and what the AI prompts are the same protocol.
The result: fewer compromised samples, fewer omitted optimal sections, and a clearer signal for the pathologist signing out the case.
